Humana announced last week that it will exit the Employer Group Commercial Medical Products business, which includes fully insured plans, self-funded plans and Federal Employee Health Benefit plans. But is this the right move…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies…
Continue Reading
By Mark Melchionna
February 28, 2023 – A recent survey from Pew Research Center found that although there are certain areas where patients see the benefits of artificial intelligence (AI) use in healthcare, the…
COVID-19 forced a spike in policy-makers’ interest and willingness to invest in public health; a spike that is unfortunately retreating to the old business as usual. (President Biden, in his State of the Union…
Continue Reading
Hims & Hers Health’s stock price is up Tuesday after the direct-to-consumer virtual care company reported nearly doubling its revenue in 2022.The company posted revenue of $526.9 million for the year compared with $271.9…
Continue Reading
By Sara Heath February 28, 2023 – Family caregivers looking for a good hospice experience might want to consider a not-for-profit hospice provider over a for-profit provider, with new data from the…
Continue Reading
By Hannah Nelson
February 28, 2023 – Two new proposed rules from The Centers for Medicare & Medicaid Services (CMS) aim to advance health information exchange (HIE) interoperability and streamline prior authorization processes.
The proposed…
By Sarai Rodriguez February 28, 2023 – According to the “Implications of Stress on CISOs 2023 Report” by Cynet, security teams are facing retention snags due to the elevated levels of work-related…
Continue Reading
Eighty percent of all respondents have used telemedicine within their lifetime and it’s now the preferred channel for receiving prescriptions and care for minor illnesses, according to Rock Health’s 2022 Digital Health Consumer Adoption…
Continue Reading
Aptinyx’s approach of treating neurological disorders by targeting a key receptor in the brain has fallen short again, this time in Parkinson’s disease. With its third clinical trial failure in less than a year,…
Continue Reading
